Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Reed

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase IINigel Vicker, Yaikat Ho, James Robinson, et al.
Bioorganic & Medicinal Chemistry|July 22, 2004
Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenasesXiangdong Su, Harshani Lawrence, Dharshini Ganeshapillai, et al.
Bioorganic & Medicinal Chemistry|March 28, 2003
D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfataseDelphine S Fischer, L W Lawrence Woo, Mary F Mahon, et al.
The Oncologist|May 2, 2007
Steroid sulfatase: a new target for the endocrine therapy of breast cancerSusannah J Stanway, Patrick Delavault, Atul Purohit, et al.
Plos One|December 11, 2013
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic miceFlorence Meyer-Losic, Simon P Newman, Joanna M Day, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivoChristopher R Ireson, David Parish, Atul Purohit, et al.
Molecular and Cellular Endocrinology|December 13, 2005
Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1Gillian M Allan, Christian Bubert, Nigel Vicker, et al.
Head & Neck|February 23, 2016
Correlating thyroid cytology and histopathology: Implications for molecular testingMichael J Reed, Steven M Sperry, Michael P Gailey, et al.
Anticancer Research|October 23, 2009
STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cellsPaul A Foster, Yaik T Ho, Simon P Newman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamateBindumalini Raobaikady, Atul Purohit, Surinder K Chander, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase IINigel Vicker, Yaikat Ho, James Robinson, et al.
Bioorganic & Medicinal Chemistry|July 22, 2004
Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenasesXiangdong Su, Harshani Lawrence, Dharshini Ganeshapillai, et al.
Bioorganic & Medicinal Chemistry|March 28, 2003
D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfataseDelphine S Fischer, L W Lawrence Woo, Mary F Mahon, et al.
The Oncologist|May 2, 2007
Steroid sulfatase: a new target for the endocrine therapy of breast cancerSusannah J Stanway, Patrick Delavault, Atul Purohit, et al.
Plos One|December 11, 2013
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic miceFlorence Meyer-Losic, Simon P Newman, Joanna M Day, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivoChristopher R Ireson, David Parish, Atul Purohit, et al.
Molecular and Cellular Endocrinology|December 13, 2005
Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1Gillian M Allan, Christian Bubert, Nigel Vicker, et al.
Head & Neck|February 23, 2016
Correlating thyroid cytology and histopathology: Implications for molecular testingMichael J Reed, Steven M Sperry, Michael P Gailey, et al.
Anticancer Research|October 23, 2009
STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cellsPaul A Foster, Yaik T Ho, Simon P Newman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamateBindumalini Raobaikady, Atul Purohit, Surinder K Chander, et al.
Pageof 8